发明公开
EP2924034A1 PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR
有权
药剂师ZUSAMMENSETZUNG MIT EINEM NICHTNUKLEOSIDISCHEN反向转录蛋白
- 专利标题： PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR
- 专利标题（中）： 药剂师ZUSAMMENSETZUNG MIT EINEM NICHTNUKLEOSIDISCHEN反向转录蛋白
-
申请号： EP15157348.2申请日： 2011-03-28
-
公开(公告)号： EP2924034A1公开(公告)日： 2015-09-30
- 发明人: Burch, Jason , Cote, Bernard
- 申请人： Merck Canada Inc.
- 申请人地址： 16711 Trans-Canada Highway Kirkland QC H9H 3L1 CA
- 专利权人： Merck Canada Inc.
- 当前专利权人： Merck Canada Inc.
- 当前专利权人地址： 16711 Trans-Canada Highway Kirkland QC H9H 3L1 CA
- 代理机构： Jaap, David Robert
- 优先权： US318824P 20100330; US321573P 20100407
- 主分类号： C07D401/06
- IPC分类号： C07D401/06 ; A61K31/4439 ; A61P31/18
摘要：
The invention relates to a pharmaceutical composition comprising an effective amount of the compound:
or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier and further comprising an effective amount of an anti-HIV agent. The invention further relates to use of said pharmaceutical composition for the prophylaxis or treatment of infection by HIV or for the prophylaxis, treatment, or delay in the onset of AIDS in a subject in need thereof.
or a pharmaceutically acceptable salt thereof and a pharmaceutically acceptable carrier and further comprising an effective amount of an anti-HIV agent. The invention further relates to use of said pharmaceutical composition for the prophylaxis or treatment of infection by HIV or for the prophylaxis, treatment, or delay in the onset of AIDS in a subject in need thereof.
公开/授权文献
信息查询
